Search

everythinglearnresearchcommunity

for

Search:↓

Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Laser Doppler velocimetry is a valuable noninvasive tool for skin blood flow research in dermatology.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Repeated botulinum toxin injections for forehead wrinkles may cause hairline recession in some women.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

The document concludes that mesotherapy can be effective for skin and hair treatments, but more research is needed to confirm its safety and effectiveness.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Using skin stem cells and certain molecules might lead to scar-free skin healing.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Hair transplantation can successfully treat stubborn alopecia areata.

Finasteride doesn't affect bone density in male rats.

The document concludes that more research is needed to understand airway repair and to improve tissue engineering for lung treatments.

Fractional lasers could help hair regrowth in androgenic alopecia, but more research is needed to confirm their effectiveness and safety.

Testosterone reduces key molecules needed for early pregnancy in rats.

Hair mesotherapy might help with certain types of hair loss but lacks strong scientific proof and has some risks.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Iron deficiency might contribute to hair loss in women.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Chronic stress in mice changes skin metabolism and gene expression, leading to hair loss.